Brought to you by 
Cardinal sells PTS business to Blackstone Group for $3.3bn
02 Feb 2007
Executive Summary
Private investment firm Blackstone Group has acquired the Pharmaceutical Technologies and Services (PTS) segment of Cardinal Health for $3.3bn in cash, paying almost twice as much as the business generates in annual sales.
Deal Industry
- Pharmaceuticals
- Services
-
Pharmaceuticals
-
Drug Delivery
- Controlled Release
-
Drug Delivery
Deal Status
- Final
Deal Type
-
Acquisition
- Buy-out
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Cardinal sells PTS business to Blackstone Group for $3.3bn
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice